Clinical outcomes between aggressive versus moderate fluid resuscitation in the management of acute pancreatitis: a quasi-experimental study

Authors

DOI:

https://doi.org/10.52442/jrmi.v12i1.1011

Keywords:

Acute Pancreatitis, Fluid Therapy, Multiple Organ Failure, Ringer’s Lactate

Abstract

Introduction: Early intravenous fluid resuscitation is essential in acute pancreatitis (AP), but the optimal volume strategy remains uncertain. Aggressive hydration raises concerns about iatrogenic damage from excessive fluid intake.

Objectives: To compare the clinical outcomes of moderate versus aggressive fluids resuscitations in the management of acute pancreatitis.

Materials and Methods: A quasi-experimental, alternate-allocation comparison study was conducted between October 2023 to March 2025. About 260 adults with first‐episode AP were enrolled and alternately assigned to aggressive (20 mL/kg bolus followed by 3 mL/kg/h) or moderate (10 mL/kg bolus if hypovolemic, followed by 1.5 mL/kg/h) lactated Ringer’s (LR) protocols. The primary endpoints comprised hospital length of stay (LOS) and incidence of persistent organ failure. Secondary outcomes included ICU admissions, treatments, SIRS (Systemic Inflammatory Response Syndrome) at 24 and 48 hours, changes in hematocrit and blood urea nitrogen (BUN), pancreatic necrosis, and in-hospital mortality.

Results: Baseline characteristics were balanced across 260 patients. About 8.5% patients on aggressive LR and 6.2% on moderate LR experienced persistent organ failure (p=0.43). Median hospital LOS for aggressive LR was 6 days (IQR 4–8) and for moderate LR was 5 days (IQR 3–7) (p=0.05). ICU admission (15.4% vs 9.2%; p=0.08), any organ failure (8.5% vs 6.2%; p=0.43), invasive interventions (10.0% vs 7.7%; p=0.49), and mortality (2.3% vs 1.5%; p= 0.67) were comparable. Despite no improvement in clinical outcomes, aggressive LR  yielded greater 24-hour reductions in hematocrit and BUN (p<0.05).

Conclusions: Larger volumes of LR did not improve outcomes in this cohort. Adoption of customized, moderate-volume techniques with regular reassessment in early AP is supported by these data.

Author Biographies

Asif Khan, Hayatabad Medical Complex, Peshawar

Consultant Gastroenterologist 

 

 

Rafi Ullah, Khyber Medical College, Peshawar

MBBS Student

Fazal Wahab, Hayatabad Medical Complex, Peshawar

Resident Gastroenterologist

Imran Ullah, Hayatabad Medical Complex, Peshawar

Assistant Professor, Gastroenterology

Intikhab Alam, Jinnah Medical College, Peshawar

Consultant Gastroenterologist

 

Laiba Ali, Khyber Medical College, Peshawar

MBBS Student

 

 

References

Xiao AY, Tan ML, Wu LM, Asrani VM, Windsor JA, Yadav D, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016;1(1):45–55. Doi:10.1016/S2468-1253(16)30004-8.

Roberts SE, Morrison-Rees S, John A, Williams JG, Brown TH, Samuel DG. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 2017;17(2):155–65. Doi:10.1016/j.pan.2017.01.005.

Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252–61. Doi:10.1053/j.gastro.2013.01.068.

Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut. 2004;53(9):1340–44. Doi:10.1136/gut.2004.039883.

Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11. Doi:10.1136/gutjnl-2012-302779.

Singh VK, Wu BU, Bollen TL, Repas K, Maurer R, Mortele KJ, et al. Early systemic inflammatory response syndrome is associated with severe acute pancreatitis. Clin Gastroenterol Hepatol. 2009;7(11):1247–51. Doi:10.1016/j.cgh.2009.08.012.

Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–15. Doi:10.1038/ajg.2013.218.

de-Madaria E, Buxbaum JL, Maisonneuve P, et al. Aggressive or moderate fluid resuscitation in acute pancreatitis. N Engl J Med. 2022;387(11):989–1000. Doi:10.1056/NEJMoa2202884.

Angsubhakorn A, Tipchaichatta K, Chirapongsathorn S. Comparison of aggressive versus standard intravenous hydration for clinical improvement among patients with mild acute pancreatitis: a randomized controlled trial. Pancreatology. 2021;21(7):1224–30. Doi:10.1016/j.pan.2021.06.004.

Wu BU, Hwang JQ, Gardner TH, Repas K, Delee R, Yu S, et al. Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9(8):710–17.e1. Doi: 10.1016/j.cgh.2011.04.026

Sohail Z, Shaikh H, Iqbal N, Masood H, Parkash O. Aetiology, presentation and outcomes of patients presenting with acute pancreatitis in a tertiary care hospital. J Pak Med Assoc. 2024;74(3):563–5. Doi:10.47391/JPMA.9279.

Leppäniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27. Doi:10.1186/s13017-019-0247-0.

Buxbaum JL, Quezada M, Da B, Jani N, Lane C, Mwengela D, et al. Early aggressive hydration hastens clinical improvement in mild acute pancreatitis. Am J Gastroenterol. 2017;112(5):797–803. Doi:10.1038/ajg.2017.40.

Cazacu SM, Parscoveanu M, Cartu D, Moraru E, Rogoveanu I, Ungureanu BS, et al. NLR48 is better than CRP and mCTSI, and similar to BISAP and SOFA scores for mortality prediction in acute pancreatitis: a comparison of six scores. J Inflamm Res. 2023;16:4793–804. Doi:10.2147/JIR.S432408.

Zhang Y, Wang M, Lu Z, Yang M. Effect of Fluid Resuscitation Strategies for Obese Patients with Sepsis and Septic Shock: A Systematic Review. Intensive Care Res. 2023;3(1):61-8. Doi: 10.1007/s44231-022-00019-y. Epub 2022 Oct 27. PMID: 36320644; PMCID: PMC9610334.

Ehsan M, Ahmad AB, Javed H, Zahid A, Aamir HS, Cheema HA, et al. Aggressive versus moderate fluid replacement for acute pancreatitis: an updated systematic review and meta-analysis. JGH Open. 2024;8(12):e70073. Doi:10.1002/jgh3.70073.

Hamesch K, Hollenbach M, Guilabert L, Lahmer T, Koch A. Practical management of severe acute pancreatitis. Eur J Intern Med. 2025;133:1–13. Doi:10.1016/j.ejim.2024.10.030.

Yang AL, Vege SS. Fluid resuscitation in acute pancreatitis: current opinion. Curr Opin Gastroenterol. 2023;39(5):411–15. Doi:10.1097/MOG.0000000000000959.

Crosignani A, Spina S, Marrazzo F, Cimbanassi S, Malbrain MLNG, Van Regenmortel N, et al. Intravenous fluid therapy in severe acute pancreatitis: evidence and operative algorithm. Ann Intensive Care. 2022;12:65. Doi:10.1186/s13613-022-01072-y.

Yaowmaneerat T, Sirinawasatien A. Update on the strategy for intravenous fluid treatment in acute pancreatitis. World J Gastrointest Pharmacol Ther. 2023;14(3):22–32. Doi:10.4292/wjgpt.v14.i3.22.

Sharma A, Bhatia R, Kapoor A, Aggarwal N, Kumar P, Shalimar, et al. Optimising early fluid therapy in acute pancreatitis: a prospective multicentre evaluation. World J Gastroenterol. 2023;29(24):3804–15. Doi:10.3748/wjg.v29.i24.3804.

Downloads

Published

2025-12-17